INTEGRATED BIOPHARMA INC
For the period ended Oct 28, 2026. Filed Oct 28, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Oct 28, 2026 · Filed Oct 28, 2026
Use the contents to explore the available documents and sections.
Contents
PROXY
| The Board of Directors recommends you vote FOR the following: | ||||||
|---|---|---|---|---|---|---|
| For | With-hold | |||||
| 1. TO ELECT THE THREE CLASS II DIRECTORS FOR A THREE-YEAR TERM TO SERVE UNTIL THE 2029 ANNUAL MEETING OF STOCKHOLDERS | NOTE: The transaction of such other business as may properly come before the Meeting or any adjournment thereof. | |||||
| 01) William Milmoe | ||||||
| 02) Christina Kay | ||||||
| 03) Robert Canarick | ||||||
| The Board of Directors recommends you vote FOR the following proposals: | ||||||
| For | Against | Abstain | ||||
| 2. To ratify the Company’s 2025 Equity Incentive Plan Proposal; and | ||||||
| 3. To ratify the appointment of CBIZ CPA’s P.C. as Integrated BioPharma Inc.’s independent accountant for the fiscal year ending June 30, 2027; and | ||||||
COMPANY ID:
PROXY NUMBER:
ACCOUNT NUMBER:
Signature _______________________________ Date_______________ Signature _____________________________________ Date _________________
NOTE: Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, trustee or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by an authorized officer.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.